๐ฐ Jun Xu News
Jun Xu News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Jun Xu. Real-time updates on events, politics, business and more.
April 25, 2024
Morgan Stanley Private Equity Asia is reorganising its teams in the region as its current chief executive of Asia Chin Chou is retiring, according to an internal memo reviewed by Reuters. ...
April 25, 2024
Morgan Stanley Private Equity Asia (PEA) is reorganising its teams in the region as its current chief executive of Asia Chin Chou is retiring, according ......
January 16, 2024
The genetic alphabet contains just four letters, referring to the four nucleotides, the biochemical building blocks that comprise all DNA. Scientists have long wondered whether itโs possible to add more letters to this alphabet by creating brand-new
December 14, 2023
<p>Researchers from UC San Diego have come one step closer to unlocking the potential of synthetic DNA, which could help scientists develop never-before-seen proteins in the lab.</p>
November 6, 2023
Verismo Therapeutics, a clinical-stage CAR-T company developing novel KIR-CAR platform technology today announced that it will be presenting at the upcoming Society for Immunotherapy of Cancer 38thAnnual Meeting (SITC 2023), to be held in San Diego
November 3, 2023
/PRNewswire/ -- Verismo Therapeutics, a clinical-stage CAR-T company developing novel KIR-CAR platform technology today announced that it will be presenting at...
August 24, 2023
This article was originally published on Aug 18 4:58 p.m. EDT by THE CITYOne woman, a low-wage worker at the New World Mall in Flushing, said that in the summer
June 6, 2023
CHARLOTTE — UNC Charlotte introduced government officials, and economic development and industry partners to two growing research areas of focus: predicting health and environmental risk and next-generation battery research during
April 11, 2023
โGoing onceโ, the auctioneer cried, adding: โIโll take 55 and a half sir,โ addressing one car enthusiast who was bidding. โIt had your name written on it.โT
December 2, 2022
The biotech company has gone from founding to Phase 1 clinical trials in less than two years, and the new space will continue accelerating its work, per leadership.